Mechanisms of estrogen receptor signaling:: Convergence of genomic and nongenomic actions on target genes

被引:1004
作者
Björnström, L [1 ]
Sjöberg, M [1 ]
机构
[1] Karolinska Inst, Dept Mol & Cell Biol, SE-17177 Stockholm, Sweden
关键词
D O I
10.1210/me.2004-0486
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estrogen receptors (ERs) act by regulating transcriptional processes. The classical mechanism of ER action involves estrogen binding to receptors in the nucleus, after which the receptors dimerize and bind to specific response elements known as estrogen response elements (EREs) located in the promoters of target genes. However, ERs can also regulate gene expression without directly binding to DNA. This occurs through protein-protein interactions with other DNA-binding transcription factors in the nucleus. In addition, membrane-associated ERs mediate nongenomic actions of estrogens, which can lead both to altered functions of proteins in the cytoplasm and to regulation of gene expression. The latter two mechanisms of ER action enable a broader range of genes to be regulated than the range that can be regulated by the classical mechanism of ER action alone. This review surveys our knowledge about the molecular mechanism by which ERs regulate the expression of genes that do not contain EREs, and it gives examples of the ways in which the genomic and nongenomic actions of ERs on target genes converge. Genomic and nongenomic actions of ERs that do not depend on EREs influence the physiology of many target tissues, and thus, increasing our understanding of the molecular mechanisms behind these actions is highly relevant for the development of novel drugs that target specific receptor actions.
引用
收藏
页码:833 / 842
页数:10
相关论文
共 103 条
  • [61] Spl binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor a promoter
    Petz, LN
    Nardulli, AM
    [J]. MOLECULAR ENDOCRINOLOGY, 2000, 14 (07) : 972 - 985
  • [62] FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells
    Philips, A
    Teyssier, C
    Galtier, F
    Rivier-Covas, C
    Rey, JM
    Rochefort, H
    Chalbos, D
    [J]. MOLECULAR ENDOCRINOLOGY, 1998, 12 (07) : 973 - 985
  • [63] Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution
    PlanasSilva, MD
    Weinberg, RA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (07) : 4059 - 4069
  • [64] Functional synergy between the transcription factor Sp1 and the estrogen receptor
    Porter, W
    Saville, B
    Hoivik, D
    Safe, S
    [J]. MOLECULAR ENDOCRINOLOGY, 1997, 11 (11) : 1569 - 1580
  • [65] Prall OWJ, 1997, J BIOL CHEM, V272, P10882
  • [66] A splice variant of estrogen receptor β missing exon 3 displays altered subnuclear localization and capacity for transcriptional activation
    Price, RH
    Butler, CA
    Webb, P
    Uht, R
    Kushner, P
    Handa, RJ
    [J]. ENDOCRINOLOGY, 2001, 142 (05) : 2039 - 2049
  • [67] RAY A, 1994, J BIOL CHEM, V269, P12940
  • [68] Plasma membrane estrogen receptors exist and functions as dimers
    Razandi, M
    Pedram, A
    Merchenthaler, I
    Greene, GL
    Levin, ER
    [J]. MOLECULAR ENDOCRINOLOGY, 2004, 18 (12) : 2854 - 2865
  • [69] ERs associate with and regulate the production of caveolin: Implications for signaling and cellular actions
    Razandi, M
    Oh, P
    Pedram, A
    Schnitzer, J
    Levin, ER
    [J]. MOLECULAR ENDOCRINOLOGY, 2002, 16 (01) : 100 - 115
  • [70] Proximal events in signaling by plasma membrane estrogen receptors
    Razandi, M
    Pedram, A
    Park, ST
    Levin, ER
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (04) : 2701 - 2712